A

ABOzymes Biomedical Inc.

11 employees

Avivo Biomedical operates as a preclinical-stage company.

Basic info

Industry

biotechnology

Sectors

Biotechnology
blood transfusion
organ transplantation
universal donor organs
enzymes
universal donor blood
Medical

Date founded

2020

Funding rounds raised

Total raised

$250K

from 2 investors over 2 rounds

A

ABOzymes Biomedical Inc. raised $250K on March 31, 2022

Investors: Genome British Columbia

A

ABOzymes Biomedical Inc. raised undisclosed on July 15, 2020

Investors: entrepreneurship@UBC

FAQ